Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 6
Submit an article Journal homepage
932
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus – Research Article

A national platform for Covid-19 vaccine studies recruitment in France: Covireivac volunteer’s characteristics

Marion Bonnetona CIC Cochin Pasteur, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France;b Innovative Clinical Research Network in Vaccinology (I-REIVAC), F-CRIN, Paris, FranceCorrespondence[email protected]
View further author information
,
Jessica Sambourga CIC Cochin Pasteur, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, FranceView further author information
,
Liem Binh Luong Nguyena CIC Cochin Pasteur, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France;c Université Paris Cité, Paris, FranceView further author information
,
Christine Trilloud French Clinical Research Infrastructure Network (F-CRIN), Inserm, Toulouse, FranceView further author information
,
Joyce Dohoud French Clinical Research Infrastructure Network (F-CRIN), Inserm, Toulouse, FranceView further author information
,
Olivier Saint Larye Collège National des Enseignants en Médecine Générale, Paris, France;f Primary Care and Prevention, CESP, Université Paris-Saclay, Le kremlin Bicetre, FranceView further author information
,
Mathieu Schuerse Collège National des Enseignants en Médecine Générale, Paris, France;g LIMICS, U1142, Sorbonne Université, Paris, FranceView further author information
,
Marie Lachâtrea CIC Cochin Pasteur, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, FranceView further author information
&
Odile Launaya CIC Cochin Pasteur, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France;b Innovative Clinical Research Network in Vaccinology (I-REIVAC), F-CRIN, Paris, France;c Université Paris Cité, Paris, FranceORCID Iconhttps://orcid.org/0000-0003-3242-7247View further author information
ORCID Icon show all
Article: 2109364 | Received 07 Mar 2022, Accepted 31 Jul 2022, Published online: 26 Aug 2022

References

  • Larson HJ, de Figueiredo A, Xiahong Z, Schulz WS, Verger P, Johnston IG, Cook AR, Jones NS. The state of vaccine confidence 2016: global insights through a 67-country survey. EBioMedicine. 2016;12:1–7. doi:10.1016/j.ebiom.2016.08.042.
  • Verger P, Fressard L, Collange F, Gautier A, Jestin C, Launay O, Raude J, Pulcini C, Peretti-Watel P. Vaccine hesitancy among general practitioners and its determinants during controversies: a national cross-sectional survey in France. EBioMedicine. 2015;2(8):891–897. doi:10.1016/j.ebiom.2015.06.018.
  • Peretti-Watel P, Verger P, Raude J, Constant A, Gautier A, Jestin C, Beck F. Dramatic change in public attitudes towards vaccination during the 2009 influenza A(H1N1) pandemic in France. Eurosurveillance. 2013;18(44):20623. doi:10.2807/1560-7917.ES2013.18.44.20623.
  • Peretti-Watel P, Seror V, Cortaredona S, Launay O, Raude J, Verger P, Fressard L, Beck F, Legleye S, L’Haridon O. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect Dis. 2020;20(7):769–770. doi:10.1016/S1473-3099(20)30426-6.
  • Detoc M, Launay O, Dualé C, Mutter C, Le Huec J-C, Lenzi N, Lucht F, Gagneux-Brunon A, Botelho-Nevers E. Barriers and motivations for participation in preventive vaccine clinical trials: experience of 5 clinical research sites. Vaccine. 2019;37(44):6633–6639. doi:10.1016/j.vaccine.2019.09.048.
  • Coronavirus Clinical Studies [Internet]. [accessed 2021 Dec 29]. https://www.coronaviruspreventionnetwork.org.
  • Andrasik MP, Broder GB, Wallace SE, Chaturvedi R, Michael NL, Bock S, Beyrer C, Oseso L, Aina J, Lucas J. Increasing black, indigenous and people of color participation in clinical trials through community engagement and recruitment goal establishment. PLoS One. 2021;16(10):e0258858. doi:10.1371/journal.pone.0258858.
  • Fillieule O. Logics of commitment in vaccine trials of the ANRS cohorts 1992-2001. J Acquir Immune Defic Syndr. 2018;79(Suppl 1):S59–68. doi:10.1097/QAI.0000000000001809.
  • Durier C, Desaint C, Launay O. Social and behavioral consequences of participation in HIV preventive vaccine trials in the ANRS COHVAC cohort. J Acquir Immune Defic Syndr. 2018;79(Suppl 1):S37–50. doi:10.1097/QAI.0000000000001807.
  • Raheja D, Davila EP, Johnson ET, Deović R, Paine M, Rouphael N. Willingness to participate in vaccine-related clinical trials among older adults. Int J Environ Res Public Health. 2018 Aug;15(8):1743. doi:10.3390/ijerph15081743.
  • Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020;38(45):7002–7006. doi:10.1016/j.vaccine.2020.09.041.
  • Sethi S, Kumar A, Mandal A, Shaikh M, Hall CA, Kirk JMW. The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond. Trials. 2021;22(1):296.
  • Population par sexe et groupe d’âges | Insee [Internet]. [accessed 2021 Dec 23]. https://www.insee.fr/fr/statistiques/2381474#figure1_radio1.
  • Harrington L, Van Damme P, Vandermeulen C, Mali S. Recruitment barriers for prophylactic vaccine trials: a study in Belgium. Vaccine. 2017 Dec;35(48):6598–6603. doi:10.1016/j.vaccine.2017.10.041.
  • Laura Z. Stratégie de vaccination contre le Sars-Cov-2. 2020;58.
  • Emploi par activité − Tableaux de l’économie française | Insee [Internet]. [accessed 2021 Dec 28]. https://www.insee.fr/fr/statistiques/4277675?sommaire=4318291#titre-bloc-3.
  • État de santé de la population − France, portrait social | Insee [Internet]. [accessed 2021 Dec 28]. https://www.insee.fr/fr/statistiques/4238405?sommaire=4238781.
  • Shamsrizi P, Kramer FJ, Addo MM, Fathi A. Characterization of individuals interested in participating in a phase I SARS-CoV-2 vaccine trial. Vaccines (Basel). 2021;9(10):1208. doi:10.3390/vaccines9101208.
  • Laires PA, Dias S, Gama A, Moniz M, Pedro AR, Soares P, Aguiar P, Nunes C. The association between chronic disease and serious COVID-19 outcomes and its influence on risk perception: survey study and database analysis. JMIR Pub Health Surveill. 2021;7(1):e22794. doi:10.2196/22794.
  • Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, Jit M. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023–1034. doi:10.1016/S0140-6736(21)00306-8.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.